Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Ganaxolone

Ganaxolone

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Ganaxolone

17 trials tracked of Ganaxolone: 4 in phase 3 or 4 and 1 with published results. The most-cited published study has 150 citations.

17Trials tracked
4Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 4 Phase 2 12 Other / NA 1
  1. Phase 3 Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder Completed · 150 cited
  2. Phase 3 Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension Completed
  3. Phase 3 Randomized Therapy In Status Epilepticus Completed
  4. Phase 3 Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy Completed
  5. Phase 2 Ganaxolone Treatment in Children With Fragile X Syndrome Completed
  6. Phase 2 A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures Completed
Show 11 more trials
  1. Phase 2 A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression Completed
  2. Phase 2 Open-label Extension to Protocol 1042-0600 Completed
  3. Phase 2 Proof-Of-Concept Investigation With a Neurosteroid Analog (Ganaxolone) as a Smoking Cessation Candidate Completed
  4. Phase 2 A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression Completed
  5. Phase 2 A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms Completed
  6. Phase 2 Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study) Completed
  7. Phase 2 Adjunctive Ganaxolone Treatment (Part A) in TSC Followed by Long-term Treatment (Part B) Completed
  8. Phase 2 Open-Label PoC Trial of Ganaxolone in Children With PCDH19 Female Pediatric Epilepsy and Other Rare Genetic Epilepsies Completed
  9. Phase 2 Ganaxolone in Posttraumatic Stress Disorder (PTSD) Completed
  10. Phase 2 A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601 Completed
  11. N/A Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone Completed

Showing the 17 most-cited and recently-updated of 17 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.